Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence survey

[1]  Bernardo A. Mainou,et al.  Community-based survey to assess seroprevalence of poliovirus antibodies in far-north Cameroon in 2020 , 2022, Vaccine: X.

[2]  Bernardo A. Mainou,et al.  Assessment of serological responses following vaccination campaigns with type 2 novel oral polio vaccine: a population-based study in Tajikistan in 2021 , 2022, The Lancet. Global health.

[3]  O. Diop,et al.  Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2020–June 2021 , 2021, MMWR. Morbidity and mortality weekly report.

[4]  Bernardo A. Mainou,et al.  A Survey to Assess Serological Prevalence of Poliovirus Antibodies in Areas With High-Risk for Vaccine-Derived Poliovirus Transmission in Chad , 2021, Journal of the Pediatric Infectious Diseases Society.

[5]  John O. Konz,et al.  Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials , 2020, The Lancet.

[6]  John O. Konz,et al.  Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials , 2020, The Lancet.

[7]  M. Pallansch,et al.  Certifying the interruption of wild poliovirus transmission in the WHO African region on the turbulent journey to a polio-free world , 2020, The Lancet. Global health.

[8]  John O. Konz,et al.  Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence , 2020, Cell host & microbe.

[9]  N. Grassly,et al.  Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine , 2020, Science.

[10]  John O. Konz,et al.  The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study , 2019, The Lancet.

[11]  J. Okeibunor,et al.  Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region , 2017, The Journal of infectious diseases.

[12]  L. Hampton,et al.  Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016. , 2016, MMWR. Morbidity and mortality weekly report.

[13]  N. Grassly.  Immunogenicity and Effectiveness of Routine Immunization With 1 or 2 Doses of Inactivated Poliovirus Vaccine: Systematic Review and Meta-analysis , 2014, The Journal of infectious diseases.

[14]  R. Sutter,et al.  Vaccine-derived polioviruses. , 2014, The Journal of infectious diseases.

[15]  R. Linkins,et al.  Prevalence of asymptomatic poliovirus infection in older children and adults in northern India: analysis of contact and enhanced community surveillance, 2009. , 2014, The Journal of infectious diseases.

[16]  G. Kang,et al.  Influence of Enteric Infections on Response to Oral Poliovirus Vaccine: A Systematic Review and Meta-analysis , 2014, The Journal of infectious diseases.

[17]  Elizabeth T Luman,et al.  Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature. , 2013, Vaccine.

[18]  D. Sack,et al.  Immune responses and protection in children in developing countries induced by oral vaccines. , 2013, Vaccine.

[19]  N. Grassly,et al.  Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus Challenge , 2012, PLoS pathogens.

[20]  M. Pallansch,et al.  Vaccine-derived polioviruses and the endgame strategy for global polio eradication. , 2005, Annual review of microbiology.

[21]  P. Wright,et al.  Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. , 1991, Reviews of infectious diseases.

[22]  M. Pallansch,et al.  Standardized Methods for Detection of Poliovirus Antibodies. , 2016, Methods in molecular biology.